Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/5469| Title: | Impact of Hepatitis B Virus (Hbv) Infection on Efficacy and Safety in the Keynote-966 Study of Pembrolizumab (Pembro) Plus Gemcitabine and Cisplatin (Gem/Cis) for Advanced Biliary Tract Cancer (Btc) | Authors: | Yau, Thomas Chan, Stephen Lam Kelley, Robin Kate Finn, Richard S. Yoo, Changhoon Furuse, Junji Qin, Shukui |
Publisher: | Lippincott Williams & Wilkins | ISSN: | 0732-183X 1527-7755 |
| Appears in Collections: | WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.